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Summary 
The dose of foreign antigen can influence whether a cell-mediated or humoral class ofirm'nune 
response is  elicited, and this may be largely accounted for by the  development of CD4 + T 
helper cells (Th) producing distinct sets of cytokines. The ability of antigen dose to direct the 
development of a Thl  or Th2 phenotype from naive CD4 + T  cells,  however, has not been 
demonstrated. In this report, we show that the antigen dose used in primary cultures could di- 
rectly affect Th phenotype development from naive DOl1.10 TCR-et[3-transgenic CD4 + T 
cells when dendritic cells or activated B cells were used as the antigen-presenting cells. Consis- 
tent with our previous findings, midrange peptide doses (0.3-0.6 p,M)  directed the develop- 
ment of Th0/Thl-like cells, which produced moderate amounts of interferon ~/ (IFN-y). As 
the peptide dose was increased, development of Thl-like cells producing increased amounts of 
IFN-'y was initially observed. At very high (>10 p,M) and very low (<0.05 b~M) doses of anti- 
genic peptide, however, a dramatic switch to development of Th2-1ike cells that produced in- 
creasing amounts of interleukin 4  (IL-4) and diminishing levels of IFN-y was observed. This 
was  true even when highly purified naive, high buoyant density CD4 + LECAM-1 hi T  cells 
were used, ruling out a possible contribution from contaminating "memory" phenotype CD4 + 
T  cells. Neutralizing anti-IL-4 antibodies completely inhibited the development of this Th2- 
like phenotype at both high and low antigen doses,  demonstrating a requirement for endoge- 
nous  IL-4.  Our findings suggest  that  the  antigen dose may affect the  levels of endogenous 
cytokines such  as  IL-4 in primary cultures, resulting in the  development of distinct Th cell 
phenotypes. 
T 
he class of immune response  (1)  that  develops upon 
exposure to foreign antigen has been attributed to het- 
erogeneity in the phenotype (Thl or Th2) of the responder 
CD4 + T cells (2). Thl cells are important for cell-mediated 
immune  responses,  and  they  produce  cytokines  such  as 
IFN-~/and lymphotoxin, which are required for the eradi- 
cation of viruses and intracellular pathogens  (2,  3).  Con- 
versely, Th2 cells are associated with allergic responses (2, 
3), are important for humoral responses (2, 3), and can reg- 
ulate Thl-type responses by their production of IL-4 and 
IL-IO (2-7). 
Many studies have indicated that different microbes or 
protein antigens, when administered using different condi- 
tions, routes, or doses,  appear to favor the selective induc- 
tion  of cell-mediated or humoral  immune  responses  (1). 
Although the dose of antigen has been shown to influence 
both the class of  immune response (1, 8, 9) and the produc- 
don ofcytokines by differentiated T cells (10-12), the mech- 
anisms  by which this may occur are poorly understood. In 
addition, a direct effect of  antigen dose on the development 
of Thl  or Th2 cells from naive CD4 + T  cells has thus far 
not been demonstrated. 
Many recent studies, both in vitro and in vivo, have in- 
dicated that cytokines present during early T cell activation 
can determine which Th phenotype develops in response 
to antigen (13). IL-12, produced by macrophages and den- 
dritic  cells  (14-16),  can  direct  the  development  of Thl 
cells,  which  produce  large  amounts  of IFN-y  (17-19). 
IL-4, which is produced by T  cells, is necessary for the de- 
velopment of Th2 cells from naive CD4 + T  cells  (6, 20- 
22).  Thus, by favoring the production of particular cyto- 
kines from the APC/accessory cell or T cells present during 
early T  cell activation,  various  factors may influence Th 
phenotype development. 
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DOll.10  TC1K-r  mouse  to  study  whether 
there is a direct effect of antigen dose on Th cell phenotype 
development. We  demonstrate  that  the  development of a 
Thl-  or Th2-1ike phenotype  from naive CD4 +  T  cells is 
strictly dependent  on  the  dose of antigen  used in primary 
cultures. 
Materials  and Methods 
Animals.  Mice  transgenic for  the  OVA323_339-specific and 
I-Aa-restricted DOl1.10 TCR-c*[3  on a BALB/c genetic back- 
ground  (23)  were bred at DNAX.  Mice heterozygous for both 
the TCtL-ot and -[3 transgenes were used for experiments. 6-8- 
wk-old female  BALB/c  mice  were  purchased  from  Simonsen 
Labs (Gilroy, CA). 
Culture Medium,  Antigen,  and  Antibodies.  Complete  tLPMI 
1640  (IKP10+) and Dutch-modified tLPMI  1640  (GIBCO Life 
Technologies  Ltd.,  Paisley,  Scotland)  were  as  previously  de- 
scribed (I6). 
Endotoxin-free OVA peptide (OVA323_339; 99% pure) was from 
Biosynthesis (Lewisville, TX). 
Purified 11Bll rat anti-mouse IL-4 mAb (24) and the isotype- 
matched control rat anti-[3-galactosidase mAb GLl13 (25) were 
supplied by J. Abrams (DNAX). Mouse cell-surface antigen-spe- 
cific mAbs used for flow cytometric sorting or analysis included 
FITC-conjugated  anti-Mac-1  (M1/70;  Caltag,  San  Francisco, 
CA),  biotinylated hamster anti-CDllc  (N418  hybridoma from 
American  Type  Culture  Collection, Rockville, MD;  26);  PE- 
conjugated  anti-B220  (1KA3-6B2)  and  anti-CD4  (RM4-5), 
FITC-conj  ugated anti-CD3 (145 -2C 11 ), CD 1 la (2D7),  CD62L 
(LECAM-1), and purified anti-CD32/CD16  (24G2)  (Phamfin- 
gen,  San  Diego,  CA.).  Rat  anti-CD8~  (53-6-7),  l-A  a,  B220 
(tKA3-6B2),  and Mac-I  (M1/70)  antibodies (either biotinylated 
or not; Phamfingen). Anti-CD4 mAb 1KL-172 (American Type 
Culture Collection) and anti-Thy-l.2 mAb (Accurate Chenfical 
Co.,  Westbury,  NY)  were  used  with  complement  (Low-Tox 
MTM; Accurate Chemical) for the lysis ofT cells. Additional mAbs 
for ELISAs, including anti-mouse IL-4 and IFN-y reagents, were 
purified from  serum-free  hybridoma supernatants  as  previously 
described (25). 
Preparation of TCR-e~3-transgenic CD4 + T Cells.  For most ex- 
periments, CD4 + T cells were purified to >99% homogeneity by 
flow  cytometry,  on  the  basis  of  staining  CD4  +  or  CD4 +- 
LECAM-1 hi,  from the spleen cells of unimmunized TC1K-cq3- 
transgenic mice as previously described (16). In some experiments, 
high buoyant density T cells were further selected on Percoll gra- 
dients (65-80% interface) before purification by flow cytometry 
as previously described (16, 27). 
Preparation of APCs.  Splenic  dendritic  cells  were  enriched 
and  then  further  purified  to  >98%  homogeneity  on  a  FAC- 
Star  el~'~|  (Becton Dickinson & Co., Mountain View, CA) on the 
basis of N418 hi (CD1 lc), Mac-t t~ staining as previously described 
(16, 28). 
High buoyant density B  cells were prepared from the spleens 
of BALB/c mice as previously described (5)  and activated with 
mitogens for 40 h at 37~  before purification by flow cytometry. 
Mitogens  included  50  btg/ml polyclonal goat  anti-IgM F(ab)'  2 
antibody fragments (Organon Teknika Corp., Durham,  NC),  a 
1:100 dilution of rat anti-mouse CD40  mAb purified from se- 
mm-fiee hybridoma supernatant (29),  or 50 txg/ml LPS (Salmo- 
nella typhosa; Sigma Immunochemicals, St. Louis, MO). Viable B 
cell blasts were collected at the end of the culture period by flota- 
tion  on Lympholyte M  TM  (Accurate Chemical)  Ficoll gradients, 
purified by flow cytometry (5)  to  >99%  purity on the basis of 
staining B220+Mac-1  CD3-,  and then viable B  cell blasts were 
again collected on Ficoll as above. 
Stimulation of Transgenic CD4+ T  cells for  Cytokine  Production. 
CD4 + T  cells (2.5  X  10S/well)  were stimulated in 2 ml RP10+ 
in 24-well plates with OVA323_339 peptide (100--0.01  IxM) and ei- 
ther B cells (2 X  10S/well)  or dendritic cells (2 X  104/well)  (irra- 
diated with 950 IZ). Some cultures received anti-lL-4 or control 
mAb (10 I~g/ml). Supernatants were collected at 24 h for deter- 
ruination  of IL-2  content  by  ELISA.  Cultures  were  expanded 
threefold into fresh  medium containing the same concentrations 
ofmAbs at 72 h. T  cell blasts (2.5  X  10  s) were harvested on day 
6, washed three times, counted, and restimulated with 5 X  10 ~' ir- 
radiated BALB/c  splenocytes and  0.6  ~M  OVA323_339 peptide. 
Supematants were collected at 48 h for determination of IFN-y 
and IL-4 content by ELISA (25).  The  lower limit of sensitivity 
for  each  of the  EL1SAs  was  125  pg/ml  (IFN-~/),  150  pg/ml 
(IL-4), and 195 pg/ml (IL-2). 
Results and Discussion 
Antigen Dose Can Direct Differential  Th Phenotype Develop- 
ment Irrespective of the  Type of APCs Used.  The dose of an- 
tigen  has  previously been  shown  to  influence  whether  a 
cell-mediated or humoral immune response develops in re- 
sponse to foreign antigen (1, 8, 9). This has been attributed 
to heterogeneity in the phenotype (Thl  or Th2)  of the re- 
sponder CD4 + T  cells (2, 3); however, a direct effect of an- 
tigen  dose  on  Th  phenotype  development  has  not  been 
demonstrated.  The  studies  that  we  and  others  have  pub- 
lished to date have used a fixed antigen dose while varying 
the type of APC to study differences in the ability of APC 
to  direct  development  of discrete  Th  subsets.  To  address 
the possible contribution of antigen dose in influencing Th 
development,  total  CD4 +  T  cells  from  the  DOl1.10 
TC1K-ixJ3-transgenic mice were allowed to develop in the 
presence of varying doses of OVA323_33,  ) peptide (100-0.01 
txM) during the primary culture period and then were re- 
stimulated with a fixed peptide dose (0.6 b~M). T  ceils from 
primary  cultures  containing  midrange  doses  of  peptide 
(0.3-0.6  txM)  produced moderate amounts  of IFN-~/ and 
very low levels of tL-4 upon restimutation (Fig. 1), consis- 
tent with our previous findings in the DOl1.10  system (6, 
16,  17). This was true regardless of whether B  cells or den- 
dritic cells were used as APC  in primary cultures  (Fig.  1). 
Addition of increasing doses of peptide to the primary cul- 
tures initially resulted in the development of Thl-like cells 
that produced increasing amounts of IFN-y and diminish- 
ing amounts of IL-4. The use of very high doses of peptide 
(>10  DM),  however,  resulted in the development of cells 
with a Th2-1ike phenotype that produced dramatically larger 
amounts oflL-4 and lower amounts oflFN-%  This overall 
trend  of Th  phenotype  development  at  different  peptide 
doses was reproducible; however,  slight shifts in the abso- 
lute dose of peptide required for the development of cells 
producing  particular  amounts  of  IFN-y  and  IL-4  were 
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of viable T  cells were recovered from primary cultures as 
peptide dose increased, except at the highest peptide con- 
centrations, where cell recoveries declined and an increase 
in the proportion of dead cells was often observed. Recov- 
ery of viable  T  cells  always  required the  presence of the 
0VA323_339 peptide;  no viable  cells were recovered when 
peptide was absent from the primary cultures. 
The mechanisms responsible for differential Th pheno- 
type development in response to antigen dose are unclear. 
Possible explanations include (a)  differential outgrowth of 
Th cells of a given phenotype; (b) differential achievement 
of threshold levels of endogenous cytokines known to be 
important for Th cell development; and (c) transmission of 
qualitatively different signals to individual T  cells at differ- 
ent antigen doses. We thus proceeded to dissect these mech- 
anisms  further. 
Th2 Development  at High Antigen Doses Does Not Require 
the Presence of T  Cells Having a Memory Phenotype.  The de- 
velopment ofa Th2 phenotype at high antigen doses could 
result from increased production of endogenous  IL-4 by 
the CD4+LECAM-11~ subset contained in the total CD4 + 
T  cell population. This CD4 + T  cell subset has previously 
been shown to be a source of significant amounts oflL-4 in 
primary  cultures  and  thereby  capable  of influencing  Th 
phenotype development and directing the development of 
Th2 cells (16,  27, 30).  This T  cell subset constitutes N5% 
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Figure  1.  Development ofa Thl  or Th2 phenotype is dependent on 
the antigen dose used in primary cultures. Flow cytometry-sorted, TCR.- 
(xl3-transgenic, CD4 + T  cells  (2.5  X  10S/well)  were cultured with flow 
cytometry-sorted dendritic cells (2  ￿  104/well)  or activated B cells  (2  ￿ 
105/well)  and  OVA323.339 peptide  (100~.01  p,M)  in  wells  of 24-well 
plates. T  cell blasts recovered after 6 d of culture were harvested, washed, 
and restimulated (2.5  ￿  10S/well)  with BALB/c splenocytes and 0.6 I-tM 
0VA323_339 peptide. Supernatants were harvested from secondary cultures 
at  48  h  and tested for  IFN-3'  and IL-4 content by ELISA.  The results 
shown are representative of three independent experiments. 
of the flow cytometry-purified total CD4 + T  cells used for 
the  antigen-dose  experiment  shown  in  Fig.  1  (data  not 
shown).  To  address  the  possible  contribution  of CD4 +- 
LECAM-1 l~ T  cells, we positively sorted by flow cytome- 
try for CD4+LECAM-1 hi T  cells  and tested the  effect of 
antigen dose on Th phenotype development by these cells. 
Surprisingly, the naive CD4+LECAM-1 hi T  cells also  de- 
veloped a  strong  Th2  phenotype  at  high  peptide  doses, 
demonstrating  that  the  presence  of CD4+LECAM-11~ T 
cells was not required for Th2 development to occur (Fig. 
2). B  cells stimulated with either anti-IgM (Fig. 2) or anti- 
IgM, LPS, and anti-CD40 in combination (Fig. 2) directed 
a similar pattern of Th development across the range of an- 
tigen doses.  The recovery ofT cells varied with the type of 
B  cell APC  used  (data  not  shown),  however,  suggesting 
that their potency as APC was not a major factor in deter- 
mining the Th phenotype developed. Of interest was  the 
development  of T  cells  capable  of producing  significant 
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Figure 2.  Development of a Th2 phenotype at high antigen doses oc- 
curs in the absence of LECAM-1 I~ CD4 § T  cells. Flow cytometry--sorted, 
TCg.-oq3-transgenic, CD4+LECAM-1 hi T  cells were cultured with den- 
dritic cells or activated B  cells and OVA323_339 peptide for 6 d, harvested, 
restimulated, and the cytokine content of 48-h supematants was deter- 
mined as described in Fig.  1. The results shown are representative of two 
independent experiments. 
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Figure 3.  High buoyant density, LECAM-1  hi CD4 + 
T cells develop a Th2 phenotype at high antigen doses. 
Flow  cytometry-sorted,  TCP,-~tl3-transgenic,  high 
buoyant density, LECAM-1  hi CD4 + T cells were cul- 
tured  with  dendritic  cells or  activated B  cells and 
0VA323_339  peptide for 6 d, harvested, restimulated, and 
the cytokine content  of 24-h  supernatants from pri- 
mary cultures and  48-h  supernatants from secondary 
cultures were determined as described in Fig. 1. The 
results shown  are representative of two  independent 
experiments. 
levels of IL-4 at  the  lowest peptide doses  (Fig. 2),  which 
was not seen when total CD4 + T  cells were used (Fig.  1). 
This  development of IL-4-producing T  cells at very low 
antigen  doses  coincided with  very  poor  recoveries  of T 
cells from primary cultures. This suggests that there may be 
preferential survival of a subset of T  cells within the initial 
CD4+LECAM-1 hi  T  cell  population  that  are  capable  of 
producing IL-4 upon restimulation. 
The possibility that CD4+LECAM-1 hl T  cells might still 
contain some T  cells precommitted to IL-4 production led 
us to make further efforts to enrich for naive CD4 + T  cells. 
To  do  this,  we  purified high  buoyant  density  cells from 
TCR.-o~-transgenic spleens on Percoll step  gradients be- 
fore sorting for CD4+LECAM-1 hi T  ceils by flow cytome- 
try. These T  cells were then cultured with either activated 
B  cell or dendritic cell APC  and varying doses of peptide. 
The  pattern  of increasing T  cell recoveries from  primary 
cultures  as  antigen  dose  increased  (Fig.  3)  was  similar to 
that seen  in previous experiments  (Figs.  1  and 2),  and we 
reasoned  that  this  might  result from  limiting amounts  of 
IL-2 being produced by the  T  cells at low antigen  doses. 
This was supported by finding that the IL-2 content of su- 
pernatants taken at 24 h  from primary cultures was low to 
undetectable at the lowest peptide doses and rose to a pla- 
teau  as peptide dose increased  (Fig. 3).  Addition of rlL-2 
(500 U/ml) to primary cultures of naive CD4+LECAM-1 hi 
T  cells with dendritic cell APC,  however,  did not signifi- 
cantly increase T  cell recoveries or alter the Th phenotype 
developed at any peptide dose (data not shown).  The pat- 
tern  of Th  phenotypes  developed from  the  high  buoyant 
density CD4+LECAM-1 hi T  cells on the different types of 
APC  was  essentially identical to  that previously seen from 
CD4+LECAM-1 hi  T  cells, with  median  peptide  doses  (1 
txM)  giving  rise  to  Thl-like  cells producing  IFN-y  and 
very high  (>10  btM)  and low  (<0.05  IxM) peptide doses 
driving the development of Th2-1ike cells producing IL-4 
(compare Figs. 2 and 3). 
Th2 Phenotype Development at High and Low Antigen Doses 
Is Dependent  on Endogenous IL-4.  IL-4 has been shown  to 
be  the  dominant  cytokine required  for development  of a 
Th2  phenotype  from  naive CD4 +  T  cells. To  determine 
whether Th2 development at high antigen doses in our sys- 
tem  was  dependent  on  endogenous  IL-4,  anti-IL-4 mAb 
was added to primary cultures of naive CD4+LECAM-lhi 
T  cells containing different doses of OVA323_339. The anti- 
IL-4  mAb  strongly  inhibited  Th2  development  at  both 
high  (100  txM)  and  low  (<0.01  IzM)  peptide  doses, 
whereas the isotype control antibody had no effect (Fig. 4). 
These  data  clearly demonstrate  that  the  development  of 
Th2-1ike  cells  resulting  from  the  addition  of very  high 
doses  of peptide  in  primary  cultures  is  IL-4  dependent. 
This  was  true  both  when  dendritic  cells  and  anti-IgM/ 
LPS/anti-CD40-activated  B  cells were  used  as  the  APC 
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Figure  4.  Endogenous IL-4 is required for Th2 phenotype develop- 
ment  at  high  antigen doses. Flow  cytometry~orted,  TCR_-0t~-trans- 
genic, LECAM-1  hi CD4 + T cells were cultured with dendritic cells and 
OVA323_339 peptide (100, 1, or 0.01 p.M) for 6 d, harvested, restimulated, 
and the cytokine content of 48-h supematants were deten'nined as de- 
scribed in Fig. 1. The primary cultures contained either anti-IL-4 mAb or 
isotype control mAb (10 p~g/ml) where indicated. The results shown are 
representative of three independent experiments. 
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described  to  produce  IL-4.  This  suggests  that  the  high 
buoyant density LECAM-1 hi population  of CD4 §  T  cells 
may be heterogeneous and contain a subpopulation of cells 
capable of producing significant amounts of IL-4 upon pri- 
mary stimulation with high doses of antigen in vitro. Alter- 
natively,  this  population  of T  cells  may be homogeneous 
and capable of producing sufficient IL-4 to direct Th2 de- 
velopment.  The  dependence  of Th2  development  at  low 
doses of antigen is surprising,  given that sufficient IL-4 to 
direct  Th2  development  is  unlikely  to be produced.  The 
Th2 cells recovered from these cultures may instead reflect 
preferential  survival of previously activated  T  cells  having 
the capacity to produce IL-4. 
Our data  are  the  first  to  show that the  dose  of antigen 
used to stimulate naive CD4 + T  cells can dictate the devel- 
opment  of a  Thl-  or Th2-1ike  phenotype.  Furthermore, 
the  development  of Th2-1ike  cells  from  naive  CD4  +  T 
cells  stimulated  with very high or low doses  of antigen  is 
IL-4  dependent.  A  default  pathway  of Th  development 
may normally operate to produce an appropriate balance of 
cell-mediated and humoral immunity for clearance of path- 
ogens.  The nature  of this response may be determined  by 
the genetic background of the host as well as the prevailing 
immune milieu  at the  time  of antigen  exposure.  This  de- 
velopmental pathway can clearly be overridden,  however, 
to obtain a higher degree of cell-mediated immunity by ac- 
tivation of macrophage/monocyte-lineage cells  to produce 
IL-12 (14-19).  Conversely, immunization with antigen in 
a manner that does not activate such cells, but induces suf- 
ficient  production  of endogenous  IL-4 by CD4 §  T  cells 
(e.g.,  high dose soluble antigen),  may shift the balance to- 
wards stronger humoral immunity by inducing the  devel- 
opment  of T  cells  producing  significant  levels  of IL-4. 
Thus,  by affecting the  balance  of cytokine production by 
the APC/accessory cells or T  cells,  a variety of factors, in- 
cluding antigen dose, may determine the class and strength 
of the immune response to foreign antigens. 
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